NasdaqGS:LFSTHealthcare
How Investors Are Reacting To LifeStance Health Group (LFST) Profit Return, Guidance Hike, And New Buyback
LifeStance Health Group recently reported its second-quarter 2026 results, posting US$435.35 million in sales and returning to profitability, while also completing a buyback of 13,000,000 shares for US$97.19 million under a previously announced program and launching a new authorization of up to US$100 million in repurchases.
Alongside raising both third-quarter and full-year 2026 revenue guidance, management pointed to clinician productivity gains, specialty service growth, and improved...